These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 1382018)

  • 1. Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.
    Todd PA; Faulds D
    Drugs; 1992 Aug; 44(2):251-77. PubMed ID: 1382018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in older patients.
    Faulds D; Sorkin EM
    Drugs Aging; 1992; 2(5):374-88. PubMed ID: 1392220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ramipril/felodipine extended-release fixed-dose combination: a review of its use in the management of essential hypertension.
    Cvetković RS; Plosker GL
    Drugs; 2005; 65(13):1851-68. PubMed ID: 16114982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Felodipine: a new dihydropyridine calcium-channel antagonist.
    Yedinak KC; Lopez LM
    DICP; 1991 Nov; 25(11):1193-206. PubMed ID: 1763537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Felodipine and isradipine: new calcium-channel-blocking agents for the treatment of hypertension.
    Walton T; Symes LR
    Clin Pharm; 1993 Apr; 12(4):261-75. PubMed ID: 8458178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Felodipine/metoprolol: a review of the fixed dose controlled release formulation in the management of essential hypertension.
    Haria M; Plosker GL; Markham A
    Drugs; 2000 Jan; 59(1):141-57. PubMed ID: 10718104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study Group.
    Gradman AH; Cutler NR; Davis PJ; Robbins JA; Weiss RJ; Wood BC
    Am J Cardiol; 1997 Feb; 79(4):431-5. PubMed ID: 9052345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC; Haggert BE; Liss C
    Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the therapeutic balance between efficacy and tolerability in antihypertensive drugs--the rationale and benefits of combining felodipine and metoprolol.
    Trenkwalder P; Elmfeldt D
    J Hum Hypertens; 1995 Jul; 9 Suppl 2():S37-42. PubMed ID: 7562898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-four-hour blood pressure monitoring during treatment with extended-release felodipine versus slow-release nifedipine in elderly patients with mild to moderate hypertension: a randomized, double-blind, cross-over study.
    Bonaduce D; Canonico V; Petretta M; Forgione L; Ianniciello A; Cavallaro V; Bertocchi F; Rengo F
    Eur J Clin Pharmacol; 1997; 53(2):95-100. PubMed ID: 9403278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
    Leenen FH; Myers MG; Joyner CD; Toal CB
    Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical efficacy and adverse effects between extended-release felodipine and atenolol in patients with mild and moderate essential hypertension.
    Chern MS; Lin FC; Wu D
    Changgeng Yi Xue Za Zhi; 1997 Jun; 20(2):86-93. PubMed ID: 9260367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists, a useful additional therapy in treatment resistant hypertension: comparison of felodipine ER and nifedipine Retard by 24-h ambulatory blood pressure monitoring.
    Dees A; Kremer Hovinga T; Breed JG; Verstappen VM; Puister SM; Meems L
    Neth J Med; 1997 Jan; 50(1):2-12. PubMed ID: 9038037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
    Dahlöf B; Hosie J
    Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W; Wilson T
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.
    Saltiel E; Ellrodt AG; Monk JP; Langley MS
    Drugs; 1988 Oct; 36(4):387-428. PubMed ID: 3069435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antihypertensive effect and pharmacokinetics of conventional and extended release felodipine tablets in patients with arterial hypertension.
    Hedner T; Elmfeldt D; Dahlöf C; Sjögren E
    Drugs; 1987; 34 Suppl 3():125-31. PubMed ID: 3443058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose-finding, placebo-controlled study on extended-release felodipine once daily in treatment of hypertension.
    Cambell LM; Ross JR; Goves JR; Lees CT; McCullagh A; Barnes P; Timerick SJ; Richardson PD
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):869-73. PubMed ID: 2481775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.